Skip to main content
OpenTrials

Clinical trial condition

Anemia, Hemolytic

Explore clinical trials studying Anemia, Hemolytic. Study availability and eligibility vary by location and protocol.

1,383 public trials 241 recruiting studies
Refine in advanced search Browse all conditions

Anemia, Hemolytic trial results

Active, Not Recruiting

Early Check: Expanded Screening in Newborns

NCT03655223

Conditions
17 Alpha-Hydroxylase Deficiency, 3-Hydroxy-3-Methylglutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, +456 more
Locations
  • RTI International Research Triangle Park, North Carolina, United States
View Trial Details
Active, Not Recruiting

Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia (TDT)

NCT05356195

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations
  • TriStar Medical Group Children's Specialists - Pediatric Oncology Nashville, Tennessee, United States
  • Hospital for Sick Children - Hematology Toronto, Canada
  • University Hospital Dusseldorf - Department of Pediatric Oncology, Hematology and Clinical Immunology Düsseldorf, Germany
  • IRCSS Ospedale Pediatrico Bambino Gesu - Dipartimento di Onco-Ematologia e Terapia Cellulare e Genica Rome, Italy
View Trial Details
Active, Not Recruiting

A Study to Test the Safety, Tolerability, and Efficacy of an Antibody, REGN7999, Injected Under the Skin for the Treatment of Iron Overload in Adult Participants With Non-Transfusion Dependent β-thalassemia, Using MRI Scans to Measure Iron Levels in the Body

NCT06421636

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations
  • Weill Cornell Medicine New York, United States
  • K Eristavi National Center of Experimental and Clinical Surgery Tbilisi, Georgia
  • Medinvest Institute of Hematology and Transfusiology Limited Tbilisi, Georgia
  • Children's Hospital Agia Sophia Athens, Attica, Greece
View all 26 locations
View Trial Details
Active, Not Recruiting

Realizing Effectiveness Across Continents With Hydroxyurea (REACH)

NCT01966731

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • Hospital Pediátrico David Bernardino Luanda, Angola
  • Centre Hospitalier Monkole Kinshasa, Democratic Republic of the Congo
  • KEMRI/Wellcome Trust Research Kilifi, Kenya
  • Ministry of Health Mbale Regional Hospital Mbale, Uganda
View Trial Details
Active, Not Recruiting

A Study Evaluating the Efficacy and Safety of Mitapivat (AG-348) in Participants With Sickle Cell Disease (RISE UP)

NCT05031780

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • University of California San Diego La Jolla, California, United States
  • UCLA Health Los Angeles, California, United States
  • Children's Hospital Oakland Oakland, California, United States
  • University of Connecticut Health Center Farmington, Connecticut, United States
View all 91 locations
View Trial Details
Active, Not Recruiting

A Long-term Safety and Efficacy Study of Danicopan as an Add-on Therapy to Complement Component 5 Inhibitor (C5i) in Participants With PNH

NCT05389449

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +8 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Baltimore, Maryland, United States
  • Research Site Kansas City, Missouri, United States
View all 45 locations
View Trial Details
Active, Not Recruiting

Specified Drug-use Surveillance of Fabhalta Capsules

NCT06606314

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Novartis Investigative Site Handa, Aichi-ken, Japan
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Okazaki, Aichi-ken, Japan
View all 91 locations
View Trial Details

Related conditions